(VIANEWS) – The NASDAQ ended the session with TherapeuticsMD (TXMD) rising 4.6% to $0.72 on Tuesday while NASDAQ Composite slid 0.14% to $14,465.93.
Today’s last reported volume for TherapeuticsMD is 2908190, 43.47% below its average volume of 5144930.
TherapeuticsMD’s last close was $0.69, 74.91% under its 52-week high of $2.75.
TherapeuticsMD’s sales growth is 33.7% for the present quarter and 29.3% for the next. The company’s growth estimates for the ongoing quarter and the next is 16.7% and 40%, respectively.
Year-on-year quarterly revenue growth grew by 114.9%, now sitting on 84.79M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
TherapeuticsMD’s stock is considered to be overbought (>=80).
TherapeuticsMD’s Stock Yearly Top and Bottom Value
TherapeuticsMD’s stock is valued at $0.72 at 17:26 EST, way under its 52-week high of $2.75 and above its 52-week low of $0.67.
TherapeuticsMD’s Moving Average
TherapeuticsMD’s worth is under its 50-day moving average of $0.76 and way below its 200-day moving average of $1.06.
More news about TherapeuticsMD (TXMD).